Invention Grant
- Patent Title: Anti-tumor drug, medicament, composition, and use thereof
- Patent Title (中): 抗肿瘤药物，药物，组合物及其用途
-
Application No.: US14157753Application Date: 2014-01-17
-
Publication No.: US09539306B2Publication Date: 2017-01-10
- Inventor: Salman Al Mahmood , Sylvie Colin
- Applicant: GENE SIGNAL INTERNATIONAL SA
- Applicant Address: CH Lausanne
- Assignee: GENE SIGNAL INTERNATIONAL SA
- Current Assignee: GENE SIGNAL INTERNATIONAL SA
- Current Assignee Address: CH Lausanne
- Agency: Young & Thompson
- Priority: EP07108349 20070516
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K38/17 ; A61K31/7088 ; A61K45/06 ; C07K14/47 ; A61K31/282 ; A61K33/24
Abstract:
A method for the treatment of cancers and/or tumors by administration of a polypeptide having the sequence SEQ ID NO:4 or a polypeptide having an amino acid SEQ ID NO Y which, when aligned with SEQ ID N: 4, has (a) a percentage of identical residues over SEQ ID NO: 4 length of at least 50%, and (b) a percentage of identical residues over a amino acid sequence SEQ ID NO Y length of at least 65% or fragments thereof having at least 20 contiguous amino acids.
Public/Granted literature
- US20140134276A1 ANTI-TUMOR DRUG, MEDICAMENT, COMPOSITION, AND USE THEREOF Public/Granted day:2014-05-15
Information query
